U.S. pharma giant copyright scrapped two experimental weight loss supplements final 12 months—a as soon as-day-to-day tablet, lotiglipron, resulting from elevated liver enzymes in addition to a 2 times-everyday capsule, danuglipron, due to solid Unintended effects—but CEO Albert Bourla has said the company is determined to “play and win” in